Neuphoria Therapeutics (NEUP) Other Accumulated Expenses (2023 - 2026)
Neuphoria Therapeutics' Other Accumulated Expenses came in at $53,165 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 80.9% from $278,149 a year earlier and down 68.7% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Going back to fiscal Q4 2023, Neuphoria Therapeutics' Other Accumulated Expenses data covers 10 quarters.
- Other Accumulated Expenses carries a three-year compound annual growth rate of 10.5% (FY2023 to FY2026).
- Going back by fiscal year, Other Accumulated Expenses was $278,149 in FY2025 (-10.6%), $311,172 in FY2024 (+689.7%) and $39,405 in FY2023.
- The fiscal Q4 2026 figure represents the lowest quarterly Other Accumulated Expenses since fiscal Q3 2025.
- Year-over-year, Other Accumulated Expenses increased in three of the last five quarters, with growth averaging 116.3%.
- Business Quant data shows NEUP's Other Accumulated Expenses at $169,666 (Q3 2026), $99,898 (Q2 2026) and $112,028 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Neuphoria Therapeutics | 437.56 Mn | 362.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,165.00 |
| Mar 31, 2026 | 169,666.00 |
| Dec 31, 2025 | 99,898.00 |
| Sep 30, 2025 | 112,028.00 |
| Jun 30, 2025 | 278,149.00 |
| Mar 31, 2025 | 32,994.00 |
| Dec 31, 2024 | 31,600.00 |
| Sep 30, 2024 | 78,649.00 |
| Jun 30, 2024 | 311,172.00 |
| Jun 30, 2023 | 39,405.00 |
API Access
Neuphoria Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();